Cargando…

Mesenchymal stem cell therapy for liver fibrosis

Currently, the most effective treatment for end-stage liver fibrosis is liver transplantation; however, transplantation is limited by a shortage of donor organs, surgical complications, immunological rejection, and high medical costs. Recently, mesenchymal stem cell (MSC) therapy has been suggested...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eom, Young Woo, Shim, Kwang Yong, Baik, Soon Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578027/ https://www.ncbi.nlm.nih.gov/pubmed/26354051 http://dx.doi.org/10.3904/kjim.2015.30.5.580

Ejemplares similares

Mesenchymal Stem Cells for the Treatment of Liver Disease: Present and Perspectives
por: Kang, Seong Hee, et al.
Publicado: (2020)

Mesenchymal stem cells to treat liver diseases
por: Eom, Young Woo, et al.
Publicado: (2020)

Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension
por: Shim, Kwang Yong, et al.
Publicado: (2018)

Therapeutic Effects of Mesenchymal Stem Cells for Patients with Chronic Liver Diseases: Systematic Review and Meta-analysis
por: Kim, Gaeun, et al.
Publicado: (2015)

Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
por: Eom, Young Woo, et al.
Publicado: (2019)

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
por: Jang, Yoon Ok, et al.
Publicado: (2015)

Ca(2+)-activated mitochondrial biogenesis and functions improve stem cell fate in Rg3-treated human mesenchymal stem cells
por: Hong, Taeui, et al.
Publicado: (2020)

Mesenchymal stem cell therapy for liver fibrosis/cirrhosis
por: Cao, Yan, et al.
Publicado: (2020)

Antifibrotic TSG-6 Expression Is Synergistically Increased in Both Cells during Coculture of Mesenchymal Stem Cells and Macrophages via the JAK/STAT Signaling Pathway
por: Gong, Seong Chan, et al.
Publicado: (2022)

Regenerative Potential of Mesenchymal Stem Cells’ (MSCs) Secretome for Liver Fibrosis Therapies
por: Nazarie (Ignat), Simona-Rebeca, et al.
Publicado: (2021)

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Bone Marrow-Derived Mesenchymal Stem Cells Isolated from Patients with Cirrhosis and Healthy Volunteers Show Comparable Characteristics
por: Lim, Yoo Li, et al.
Publicado: (2020)

Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
por: Jang, Yoon Ok, et al.
Publicado: (2014)

Immunomodulatory role of mesenchymal stem cell therapy in liver fibrosis
por: Liu, Peng, et al.
Publicado: (2023)

Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression
por: Rhee, Ki-Jong, et al.
Publicado: (2015)

Mesenchymal Stem Cell Therapy in Acute Liver Failure
por: Wang, Yong-Hong, et al.
Publicado: (2023)

Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis
por: Lee, Chanbin, et al.
Publicado: (2021)

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages
por: Yoon, Yongdae, et al.
Publicado: (2023)

Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis
por: Hu, Chenxia, et al.
Publicado: (2019)

The Effects of Programmed Cell Death of Mesenchymal Stem Cells on the Development of Liver Fibrosis
por: Wu, Hong-wei, et al.
Publicado: (2023)

Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis
por: Kim, Gaeun, et al.
Publicado: (2017)

Mesenchymal stem cells-based therapy in liver diseases
por: Han, Heng-Tong, et al.
Publicado: (2022)

Progress in mesenchymal stem cell–based therapy for acute liver failure
por: Wang, Yong-Hong, et al.
Publicado: (2018)

Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination
por: Chuang, Hong-Meng, et al.
Publicado: (2018)

Mesenchymal stem cells in idiopathic pulmonary fibrosis
por: Li, Xiaohong, et al.
Publicado: (2017)

Non-alcoholic fatty liver disease: Definition and subtypes
por: Han, Seul Ki, et al.
Publicado: (2023)

Applications of Mesenchymal Stem Cells in Liver Fibrosis: Novel Strategies, Mechanisms, and Clinical Practice
por: Zhu, Mengmei, et al.
Publicado: (2021)

Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
por: Iwasawa, Takahiro, et al.
Publicado: (2021)

Human Liver Stem Cell Transplantation Alleviates Liver Fibrosis in a Rat Model of CCl(4)-Induced Liver Fibrosis
por: Lee, Ji-Hyun, et al.
Publicado: (2021)

Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways
por: Lee, Kyong Joo, et al.
Publicado: (2018)

The mesenchymal stem cell secretome as an acellular regenerative therapy for liver disease
por: Driscoll, Julia, et al.
Publicado: (2019)

Mesenchymal stem cell therapy for liver disease: full of chances and challenges
por: Yang, Xue, et al.
Publicado: (2020)

Mesenchymal stem cells and Interleukin-6 attenuate liver fibrosis in mice
por: Nasir, Ghazanfar Ali, et al.
Publicado: (2013)

Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy
por: Zhuang, Quan, et al.
Publicado: (2019)

The Role of Mesenchymal Stem Cells in Radiation-Induced Lung Fibrosis
por: Zanoni, Michele, et al.
Publicado: (2019)

A pooled analysis of mesenchymal stem cell-based therapy for liver disease
por: Zhao, Lu, et al.
Publicado: (2018)

Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia
por: Tang, Eireen, et al.
Publicado: (2022)

Nitric oxide augments mesenchymal stem cell ability to repair liver fibrosis
por: Ali, Gibran, et al.
Publicado: (2012)

Amelioration of Murine Schistosoma mansoni Induced Liver Fibrosis by Mesenchymal Stem Cells
por: Abdel Aziz, MT, et al.
Publicado: (2012)

The role of mesenchymal stem cells in liver injury
por: Sun, Haoyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_714ehisvdvmgosi5hr7d6cqqd5